Genetron Holdings Limited logo
Genetron Holdings Limited GTH

Annual report 2022
added 12-21-2024

report update icon

Genetron Holdings Limited Financial Ratios 2011-2026 | GTH

Annual Financial Ratios Genetron Holdings Limited

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

- -3.1 -0.5 -0.4 -0.1 -1.8 - - - - - -

P/S

- 2.9 3.9 0.8 0.3 7.5 - - - - - -

EPS

- -1.1 -10.2 -5.4 -4.1 - - - - - - -

EV (Enterprise Value)

251 M 1.21 B 566 M 2.46 B 1.31 B 1.18 B - - - - - -

EBITDA per Share

- -1.12 -3.97 -4.53 -3.37 -1.97 - - - - - -

EV/EBITDA

-2.7 -1.2 -0.0 -0.3 -0.6 - - - - - -

PEG

- -0.0 0.05 -0.2 0.18 - - - - - -

P/B

- 1.3 1.0 -0.1 -0.1 -1.2 - - - - - -

P/CF

- -2.9 -5.5 -1.3 -0.3 -0.8 - - - - - -

ROE %

- - -181.33 38.02 43.70 67.61 - - - - - -

ROA %

- -33.12 -155.80 -117.88 -143.32 -95.28 - - - - - -

ROCE %

- - -15.41 -85.06 -90.77 -38.95 - - - - - -

Current Ratio

2.3 4.9 7.1 0.2 0.2 8.1 - - - - - -

DSO

- - - - - 122.3 - - - - - -

DIO

- - - - - 62.8 - - - - - -

DPO

- - - - - 43.5 - - - - - -

Operating Cycle

- - - - - 185.1 - - - - - -

Cash Conversion Cycle

- - - - - 141.6 - - - - - -

All numbers in CNY currency

Quarterly Financial Ratios Genetron Holdings Limited

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Current Ratio

- - - - 4.9 - - - 7.1 - - - 0.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in CNY currency

Multiples are an important financial analysis tool for the company Genetron Holdings Limited, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.

Advantages of Using Financial Ratios
  • Simplified Data Analysis
    Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition.
  • Comparability Between Companies
    Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations.
  • Identification of Trends and Issues
    Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks.
  • Decision Support
    Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions.
  • Accelerated Assessment of Investment Attractiveness
    Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.

Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.

Financial Ratios of other stocks in the Diagnostics research industry

Issuer Price % 24h Market Cap Country
Agilent Technologies Agilent Technologies
A
$ 112.78 0.68 % $ 34.3 B usaUSA
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
Biomerica Biomerica
BMRA
$ 2.13 - $ 4.89 M usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
$ 16.31 -0.12 % $ 493 M usaUSA
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Enzo Biochem Enzo Biochem
ENZ
- -8.98 % $ 14.8 K usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
$ 74.22 -1.99 % $ 5.01 B usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
- - $ 9.42 M israelIsrael
Medpace Holdings Medpace Holdings
MEDP
$ 457.05 0.03 % $ 13.2 B usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
- - $ 562 M britainBritain
Mettler-Toledo International Mettler-Toledo International
MTD
$ 1 242.53 0.28 % $ 25.6 B schweizSchweiz
Myriad Genetics Myriad Genetics
MYGN
$ 4.59 -1.61 % $ 425 M usaUSA
DermTech DermTech
DMTK
- -11.32 % $ 2.94 M usaUSA
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
Pacific Biosciences of California Pacific Biosciences of California
PACB
$ 1.37 -1.8 % $ 411 M usaUSA
Co-Diagnostics Co-Diagnostics
CODX
$ 4.4 101.83 % $ 129 M usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Fluidigm Corporation Fluidigm Corporation
FLDM
- 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
Precipio Precipio
PRPO
$ 26.85 -0.3 % $ 34.8 M usaUSA
Personalis Personalis
PSNL
$ 7.51 -1.38 % $ 445 M usaUSA
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
- - $ 10.7 B usaUSA
RadNet RadNet
RDNT
$ 59.53 -3.58 % $ 4.48 B usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
$ 157.49 -0.32 % $ 7.81 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 164.98 -1.19 % $ 28.4 B usaUSA
Senseonics Holdings Senseonics Holdings
SENS
$ 6.58 -0.6 % $ 275 M usaUSA
Sotera Health Company Sotera Health Company
SHC
$ 13.78 -0.76 % $ 3.91 B usaUSA
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
Invitae Corporation Invitae Corporation
NVTA
- - $ 21.2 M usaUSA
BioNano Genomics BioNano Genomics
BNGO
$ 1.21 -17.47 % $ 6.59 M usaUSA
National Research Corporation National Research Corporation
NRC
$ 17.47 -0.26 % $ 391 M usaUSA
Neuronetics Neuronetics
STIM
$ 1.54 -4.06 % $ 102 M usaUSA
Interpace Biosciences Interpace Biosciences
IDXG
$ 1.71 0.73 % $ 7.5 M usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
$ 572.18 -1.09 % $ 46 B usaUSA
Illumina Illumina
ILMN
$ 124.58 0.64 % $ 19.8 B usaUSA
ICON Public Limited Company ICON Public Limited Company
ICLR
$ 99.8 -0.55 % $ 8.23 B irlandaIrlanda
Guardant Health Guardant Health
GH
$ 82.96 -2.36 % $ 10.4 B usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
- - $ 10.6 B niderlandNiderland
Twist Bioscience Corporation Twist Bioscience Corporation
TWST
$ 44.3 -0.45 % $ 2.65 B usaUSA
Celcuity Celcuity
CELC
$ 100.81 -5.57 % $ 3.98 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
$ 263.8 -0.23 % $ 21.9 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
- -34.28 % $ 263 K israelIsrael
ENDRA Life Sciences ENDRA Life Sciences
NDRA
$ 3.41 -2.16 % $ 1.83 M usaUSA
NeoGenomics NeoGenomics
NEO
$ 7.9 -2.47 % $ 1.01 B usaUSA
Natera Natera
NTRA
$ 194.02 -3.03 % $ 19.1 B usaUSA
CareDx, Inc CareDx, Inc
CDNA
$ 17.35 -1.2 % $ 925 M usaUSA
OPKO Health OPKO Health
OPK
$ 1.14 -1.3 % $ 791 M usaUSA